Aged PROP1 deficient dwarf mice maintain ACTH production

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Nasonkin, Igor O ^a   Ward, Robert D ^b   Bavers, David L ^a   Beuschlein, Felix ^a,c   Mortensen, Amanda H ^a   Keegan, Catherine E ^a,b   Hammer, Gary D ^a,b   Camper, Sally A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUCOSE; GROWTH HORMONE; HOMEODOMAIN PROTEIN; PROLACTIN; PROPHET OF PIT 1 PROTEIN; PROPHET OF PIT-1 PROTEIN;

ADRENAL GLAND EXAMINATION; ADULT ANIMAL; ADULTHOOD; AGED; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DISEASE ASSOCIATION; DWARFISM; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HOMOZYGOTE; HORMONE SYNTHESIS; HYPOGLYCEMIA; HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; JUVENILE ANIMAL; LETHALITY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; WASTING PHENOTYPE; WEANING; WILD TYPE; AGING; ANIMAL; BLOOD; C57BL MOUSE; ENZYME IMMUNOASSAY; GENETICS; HYPOPITUITARISM; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; RADIOIMMUNOASSAY;

ADRENOCORTICOTROPIC HORMONE; AGING; ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; DWARFISM; FEMALE; GROWTH HORMONE; HOMEODOMAIN PROTEINS; HOMOZYGOTE; HYPOPITUITARISM; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PHENOTYPE; PROLACTIN; RADIOIMMUNOASSAY;

EID: 82455167218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028355     Document Type: Article

References (59)

1. Procter AM, Phillips JA 3rd, Cooper DN, (1998) The molecular genetics of growth hormone deficiency. Hum Genet 103: 255-272.
2. Vimpani GV, Vimpani AF, Lidgard GP, Cameron EHD, Farquhar JW, (1977) Prevalence of severe growth hormone deficiency. British Medical Journal 2: 427-430.
3. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT, (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30: 790-829.
4. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, et al. (1992) Mutations in the PIT-1 Gene in Children with Combined Pituitary Hormone Deficiency. Biochemical and Biophysical Research Communications 189: 851-855.
5. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, et al. (1992) A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257: 1115-1118.
6. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, et al. (1992) Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257: 1118-1121.
7. Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP, (1999) Heritable Disorders of Pituitary Development. Journal of Clinical Endocrinology and Metabolism 84: 4362-4370.
8. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, et al. (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18: 147-149.
9. Cogan J, Wu W, Phillips JI, Arnhold I, Agapito A, et al. (1998) The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. Journal of Clinical Endocrinology & Metabolism 83: 3346-3349.
10. Fluck C, Deladoey J, Rutishauser K, Eble A, Marti U, et al. (1998) Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg->Cys at codon 120 (R120C). J Clin Endocrinol Metab 83: 3727-3734.
11. Pernasetti F, Toledo SP, Vasilyev VV, Hayashida CY, Cogan JD, et al. (2000) Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 85: 390-397.
12. Agarwal G, Bhatia V, Cook S, Thomas PQ, (2000) Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 85: 4556-4561.
13. Bottner A, Keller E, Kratzsch J, Stobbe H, Weigel JF, et al. (2004) PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab 89: 5256-5265.
14. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, et al. (1999) Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab 84: 942-945.
15. Riepe FG, Partsch CJ, Blankenstein O, Monig H, Pfaffle RW, et al. (2001) Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J Clin Endocrinol Metab 86: 4353-4357.
16. Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS, (1993) Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice. Endocrinology 132: 2518-2524.
17. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, et al. (1996) The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 10: 1570-1581.
18. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, et al. (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384: 327-333.
19. Nasonkin IO, Ward RD, Raetzman LT, Seasholtz AF, Saunders TL, et al. (2004) Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 13: 2727-2735.
20. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, et al. (2005) Role of PROP1 in pituitary gland growth. Mol Endocrinol 19: 698-710.
21. Ward RD, Stone BM, Raetzman LT, Camper SA, (2006) Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 20: 1378-1390.
22. Roux M, Bartke A, Dumont F, Dubois MP, (1982) Immunohistological study of the anterior pituitary gland-pars distalis and pars intermedia-in dwarf mice. Cell and Tissue Research 223: 415-420.
23. Andersen B, Pearse RV 2nd, Jenne K, Sornson M, Lin SC, et al. (1995) The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 172: 495-503.
24. Job JC, (1989) Early diagnosis and early treatment of growth hormone deficiency. Horm Res 31: 149-152.
25. Burrows HL, Nakajima M, Lesh JS, Goosens KA, Samuelson LC, et al. (1998) Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice. Journal of Clinical Investigation 101: 1439-1447.
26. Karolyi IJ, Burrows HL, Ramesh TM, Nakajima M, Lesh JS, et al. (1999) Altered anxiety and weight gain in corticotropin-releasing hormone- binding protein-deficient mice. Proc Natl Acad Sci USA 96: 11595-11600.
27. Babu PS, Bavers DL, Beuschlein F, Shah S, Jeffs B, et al. (2002) Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 143: 665-673.
28. Lindsay JR, Shanmugam VK, Oldfield EH, Remaley AT, Nieman LK, (2006) A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing's syndrome. J Endocrinol Invest 29: 983-988.
29. Piekorz RP, Gingras S, Hoffmeyer A, Ihle JN, Weinstein Y, (2005) Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase. Mol Endocrinol 19: 431-440.
30. Buckwalter MS, Katz RW, Camper SA, (1991) Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 10: 515-526.
31. Borg KE, Brown-Borg HM, Bartke A, (1995) Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc Exp Biol Med 210: 126-133.
32. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A, (1996) Dwarf mice and the ageing process. Nature 384: 33.
33. Chrousos GP, Gold PW, (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
34. Chrousos GP, (1998) Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 851: 311-335.
35. Markowska A, Rebuffat P, Rocco S, Gottardo G, Mazzocchi G, et al. (1993) Evidence that an extrahypothalamic pituitary corticotropin-releasing hormone (CRH)/adrenocorticotropin (ACTH) system controls adrenal growth and secretion in rats. Cell Tissue Res 272: 439-445.
36. Coulter CL, Ross JT, Owens JA, Bennett HP, McMillen IC, (2002) Role of pituitary POMC-peptides and insulin-like growth factor II in the developmental biology of the adrenal gland. Arch Physiol Biochem 110: 99-105.
37. Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, et al. (2004) The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145: 4721-4727.
38. Stratakis CA, Bossis I, (2004) Genetics of the adrenal gland. Rev Endocr Metab Disord 5: 53-68.
39. Holmes PV, Dickson AD, (1971) X-zone degeneration in the adrenal glands of adult and immature female mice. J Anat 108: 159-168.
40. Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, et al. (2003) Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol Cell Bio 23: 3951-3964.
41. Shire JG, Hambly EA, (1973) The adrenal glands of mice with hereditary pituitary dwarfism. Acta Pathol Microbiol Scand A 81: 225-228.
42. Ghayee HK, Rege J, Watumull LM, Nwariaku FE, Carrick KS, et al. (2011) Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome. J Clin Endocrinol Metab 96: E243-250.
43. Gotoh H, Sagai T, Hata J, Shiroishi T, Moriwaki K, (1988) Steroid 21-hydroxylase deficiency in mice. Endocrinology 123: 1923-1927.
44. Wang X, Liu Z, Eimerl S, Timberg R, Weiss AM, et al. (1998) Effect of truncated forms of the steroidogenic acute regulatory protein on intramitochondrial cholesterol transfer. Endocrinology 139: 3903-3912.
45. Black SM, Szklarz GD, Harikrishna JA, Lin D, Wolf CR, et al. (1993) Regulation of proteins in the cholesterol side-chain cleavage system in JEG-3 and Y-1 cells. Endocrinology 132: 539-545.
46. Mesiano S, Jaffe RB, (1997) Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 18: 378-403.
47. Gage PJ, Lossie AC, Scarlett LM, Lloyd RV, Camper SA, (1995) Ames dwarf mice exhibit somatotrope commitment but lack growth hormone-releasing factor response. Endocrinology 136: 1161-1167.
48. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A, (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229: 141-162.
49. Laron Z, (2004) Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab 89: 1031-1044.
50. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, et al. (2003) Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144: 3799-3810.
51. Scheys JO, Heaton JH, Hammer GD, (2011) Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology 152: 3430-3439.
52. Zhang L, Rubins NE, Ahima RS, Greenbaum LE, Kaestner KH, (2005) Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2 141-148.
53. Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, et al. (2004) Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr 144: 430-436.
54. Taback SP, Dean HJ, (1996) Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab 81: 1693-1696.
55. Sadeghi-Nejad A, Senior B, (1974) A familial syndrome of isolated "aplasia" of the anterior pituitary. Journal of Pediatrics 84: 79-84.
56. Sobrier ML, Maghnie M, Vie-Luton MP, Secco A, Di Iorgi N, et al. (2006) Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. J Clin Endocrinol Metab 91: 4528-4536.
57. Hussain K, Challis B, Rocha N, Payne F, Minic M, et al. (2011) An Activating Mutation of AKT2 and Human Hypoglycemia. Science 334: 474.
58. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, et al. (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: 1325-1328.
59. Hershkovitz L, Beuschlein F, Klammer S, Krup M, Weinstein Y, (2007) Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. Endocrinology 148: 976-988.